17% profit growth masks a quarter-on-quarter stumble — and fee income that won't recover
Reported PAT jumped 17.2% year-on-year to ₹377.7 Cr, but declined 7.3% sequentially from Q4. Management's claims on fee recovery and MSME growth don't hold up under scrutiny.
₹377.7 Cr
+17.2% vs ₹323 Cr
−₹30+ Cr
−7.3% QoQ from Q4
South Indian Bank delivered the year-over-year numbers — profit up 17.2%, the highest NII ever at ₹1,025 Cr, loan growth at 17% crushing the 15–16% guidance. On the surface, a strong quarter. But the sequential PAT decline of 7.3% despite NII momentum tells a different story. Management blamed lower recovery income (₹179 Cr, a seasonal trough) but did not quantify why — with all that NII growth — profit still shrunk quarter-on-quarter.
The reported strength, under pressure
Net profit ₹377.7 Cr sits atop three solid drivers: NII expanded 23% YoY to ₹1,025 Cr (highest ever, driven by deposit repricing 40–60 bps and CASA growth at 15%). Loan growth hit 17%, led by gold loans (₹24,930 Cr, +43% YoY) and retail (mortgage +34%, auto +34%). Asset quality improved sharply: Gross NPA down 177 bps to a best-in-class 1.38%, Net NPA down to 26 bps. But these wins were offset by sequential profit decline, fee income deterioration, and MSME growth stalling.
Loan growth 15–16% FY27
Q1 delivered 17% (₹104,368 Cr); retail and gold strong. Retail segments (mortgage +34%, auto +34%) all tracking.
Supported
NIM to widen from rate repricing
Delivered +28 bps QoQ, +20 bps YoY to 3.23%. Deposit repricing 40–60 bps and CASA growth (19% avg) baked in.
Supported
Fee income is one-off; will recover to ₹191 Cr
Core fees ₹179 Cr Q1, down from ₹191 Cr Q4, and down from ₹188 Cr prior year Q1. Weakness now 2+ quarters; Treasury/FX at ₹44 Cr (80% below Q1 prior year). Recovery timeline not given.
Overstated
MSME loans strong focus; 17% growth
Business loans (MSME) grew 17% to ₹14,391 Cr, but ED explicitly said growth 'muted from expectations' due to 'too many uncertainties.' No acceleration visible; 'scale mode' recovery promised for Q2+.
Overstated
Asset quality robust; credit costs at 9 bps
Gross NPA 1.38%, excellent. But MD noted 9 bps is 'generous side' and likely to normalize up. Slippage guidance ₹500–800 Cr FY27.
Supported (with caveat)
What changed on this call
Corporate portfolio now 40% of advances vs 30% strategic target. MD rationalized as opportunistic (West Asia, tight liquidity, pricing +40–50 bps). Positions 'short-duration'; intent to wind down. Marks a strategic pivot away from Retail/MSME in practice.
Fee income guidance implicitly withdrawn. Previously implied recovery; now described as 'one-off technical issue' (product renewal process). Treasury/FX collapsed (80% below Q1 last year). No recovery timeline stated.
MSME growth 'muted'. ED admitted growth below expectations due to 'too many uncertainties.' Expecting 'scale mode' to resume Q2. Underlying strategy intact but execution proven soft.
NIM trajectory upgraded (conditional on rate cycle). MD expects further hardening 'if rate cycle turns.' Deposit repricing baked in; CASA growth (19% average) a cost buffer.
Operating leverage target affirmed but not achieved in Q1. Q1 did not deliver it; FY27 target reaffirmed. OpEx growth 5–6%; revenue growth expected higher (confidence on NII traction, business lines). No acceleration visible yet.
MD P.R. Seshadri announced departure. This is his last earnings call. Third MD in three years (prior MD also left after three years). MD explicitly declined to bind successor with concrete ROE/margin targets.
The bull-bear ledger
NII at ₹1,025 Cr highest ever; +23% YoY on deposit repricing and CASA lift
Loan growth 17% beats guidance; retail momentum (mortgage +34%, auto +34%, gold +43%) broad-based
Gross NPA 1.38%, Net NPA 26 bps — industry-leading asset quality; provision coverage 94.51%
CASA growth 15% YoY (₹41,496 Cr); 65%+ of deposits provides cost buffer
Core fee income down ₹12 Cr QoQ and down YoY (₹179 Cr vs ₹188 Cr prior Q1). 'One-off' claim not supported by 2+ quarter trend
PAT declined 7.3% QoQ despite NII strength — sequential momentum broken; recovery shortfall (₹179 Cr) unquantified
MSME growth admitted 'muted from expectations'; core strategic pivot at execution risk
Corporate portfolio 40% vs 30% target — short-duration claim offers limited downside protection if West Asia escalates
NIM guidance hedged on rate cycle turning up; if cycle stays flat or cuts resume, tailwind evaporates
MD departure with no forward guidance; third leadership change in three years raises governance/continuity risk
Risks, ranked by concern to a holder
Fee income structural weakness, not one-off
MediumCore fees ₹179 Cr down from ₹191 Cr (Q4), ₹188 Cr (prior Q1). Treasury/FX at ₹44 Cr (80% below). Two-quarter trend contradicts 'technical issue' narrative. Trade/FX platform launch (Sept) expected to lift 40–50% YoY, but timeline uncertain and recovery not guaranteed.
Sequential PAT decline unexplained
MediumQ1 PAT ₹377.7 Cr down 7.3% QoQ despite NII +23% YoY. Recovery income shortfall (₹179 Cr vs normal higher) cited but quantified impact not given. Suggests headwinds elsewhere (fee, provisions, other income) offsetting NII gains.
MSME strategic pivot stalled in execution
MediumBusiness loans grew 17% but ED explicitly admitted growth 'muted from expectations' due to 'too many uncertainties.' This is core to balance-sheet mix shift (reduce corporate, increase MSME). If slowdown persists, strategic credibility damaged.
Corporate portfolio overweight amid geopolitical risk
MediumCorporate now 40% vs 30% strategic target (short-duration, West Asia-weighted). If West Asia crisis deepens or liquidity conditions tighten, forced asset sales or defaults spike. Management asserts 'short-duration' and 'roll off at will,' but no hedge disclosed.
Leadership transition; third MD in three years
MediumMD P.R. Seshadri departing after earnings call. Prior MD also left after three years. Leadership churn raises questions on strategy continuity, execution pace, and board succession planning. MD explicitly declined to bind successor with forward guidance.
NIM guidance conditional on rate cycle reversal
LowMD expects NIM to 'harden if rate cycle turns to increases' (T+1 sensitivity). But if rate cycle stays flat or cuts resume, NIM tailwind evaporates. No base-case guidance on margins without rate hikes. Deposit repricing already baked in; sharp further gains unlikely.
How the market is positioned
The post-result price action tells a story: day-1 selloff of −1.74% followed by a strong recovery to +4.16% by day 3. The market initially dismissed the quarter-on-quarter PAT decline, then re-rated on the year-over-year beat and NIM trajectory. As of 2026-07-22, the stock trades at ₹48, now −3.81% from its all-time high but above key moving averages (SMA20 ₹45.81, SMA50 ₹44.17, SMA200 ₹40.18). The stock is up +65.92% from its 52-week low, a rally that reflects institutional accumulation.
Ownership flows show FII inflow of +3.27pp to 24.21% (vs 20.94% last quarter) — institutions are adding, not trimming. DII backing off slightly (−1.04pp to 12.76%) and promoter absent. The FII ramp into SIB is a vote of confidence on the deposit-repricing and loan-growth narrative, but it also means the stock is now vendor-heavy into the Q2 print. If fee weakness persists or MSME recovery falters, foreign buyers may recalibrate.
What to watch next
1 · Core fee income recovery (Trade/FX platform, Sept launch)
Management claims +40–50% YoY growth from new platform by end-September. If the platform launches on time and core fees recover to ₹191 Cr+ by Q2/Q3, the 'one-off' narrative holds. If not, fee income is structural and PAT growth significantly constrained. This is the biggest wild card.
2 · MSME growth reacceleration (Q2 onwards)
ED promised 'scale mode' resumption post-uncertainties. If business loans reaccelerate to 18–20% growth in Q2/Q3, strategic pivot is on track. If growth remains 'muted' (sub-15%), balance-sheet mix shift is stalled and the corporate overshoot becomes a permanent constraint.
3 · QoQ PAT recovery into Q2
Q1 PAT ₹377.7 Cr was −7.3% QoQ. If recovery income normalizes (guidance ₹800–1,000 Cr FY27; Q1 only ₹179 Cr) and fee platform contributes, Q2 should show QoQ profit growth. If not, the organic momentum narrative is broken.
South Indian Bank is a well-run franchise on the deposit and asset-quality fronts, but this quarter shows execution cracks. Year-over-year profit growth is real, but quarter-on-quarter decline, unresolved fee weakness, and MSME stall are red flags. Management has a credibility problem: the 'one-off fee' story doesn't hold up, and the MSME pivot is demonstrably softer than guided. The bank's next move is Q2 — if core fees recover (platform launch) and MSME re-accelerates, the narrative holds. If not, the stock re-rates lower.
For holders: the stock has momentum (FII inflow, technical strength, up 65% off lows) but downside risk is rising as credibility frays. For new money: wait for Q2 print to see if fee recovery and MSME traction are real. The single number to track from here is core fee income — if it stays under ₹185 Cr in Q2, the structural weakness thesis wins and the bull case fades.
South Indian Bank Q1: PAT +17% YoY to ₹378 Cr as low provisions flatter a core slowdown
PAT +17.22% YoY · revenue +11.23% · margins expanding
₹2,627.81 Cr
+11.23% YoY
₹377.66 Cr
+17.22% YoY
12.56%
+1.8pp YoY
₹1.44
South Indian Bank posted consolidated net profit of ₹377.66 Cr for Q1 FY27, up 17.2% YoY from ₹322.17 Cr but down 7.3% sequentially from ₹407.40 Cr; standalone is effectively identical (₹377.63 Cr). Interest earned rose 11.2% YoY to ₹2,627.81 Cr, and the core engine was strong — net interest income climbed ~23% YoY to ~₹1,024.7 Cr, confirming the NIM-widening story management laid out on the Q4 concall as the book tilts to higher-yielding retail/MSME. EPS was ₹1.44 versus ₹1.23 a year ago.
Q1 FY-2027 vs prior quarters
The quality of the print is the real story. Operating profit actually FELL ~12% YoY to ₹591.84 Cr, because other income collapsed 39% YoY to ₹379.49 Cr (treasury segment result dropped from ₹203.69 Cr to ₹87.46 Cr as last year's investment gains did not repeat). PAT still grew only because provisions and contingencies fell 65% YoY — from ₹239.26 Cr to just ₹84.34 Cr. Management had explicitly guided that credit costs would 'normalize upwards from their recent unsustainable trough'; this quarter shows the trough persisting, which flatters the bottom line rather than validating operating momentum. Net profit margin therefore reads as expanding YoY (10.79% → 12.56%) even as operating margin compressed sharply (22.52% → 19.68%).
The stock went into the print at ₹45.3, down 4% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters; PAT has now risen for 3 consecutive quarters; revenue is at a 6-quarter high.
Management guides for loan growth of 15-16% in FY27, aiming to at least match the industry average. Net Interest Margins (NIMs) are expected to continue widening, driven by a strategic shift in the loan mix towards higher-yielding Retail and MSME segments and the bank's sensitivity to potential rate changes. While asse
— This quarter: met
Growth and asset quality were the genuine bright spots. Gross advances rose 17% YoY to ₹1.04 lakh Cr (the Jul 1 update), running ahead of management's 15-16% FY27 loan-growth guidance; deposits grew ~11% YoY. Gross NPA improved to 1.38% from 3.15% a year ago (Net NPA 0.26% vs 0.68%) and annualised RoA held at 1.07%. No street consensus for this specific quarter was available in our records or on the web, so vsStreet is unknown. The quarter also lands amid a leadership transition: results were signed by MD & CEO PR Seshadri, while RBI on Jul 8 approved Mahesh Muralidhar Pai as the incoming MD & CEO — a continuity question for the growth-and-margin strategy going into FY27.
What to watch
W1
Credit-cost normalization: provisions still at a ₹84 Cr trough vs ₹239 Cr YoY; management guided a rise — watch the drag on PAT next quarter.
W2
NIM/NII trajectory: NII +23% YoY held this quarter; verify the retail/MSME mix shift keeps margins widening.
W3
Other income recovery: treasury-led other income down 39% YoY to ₹379 Cr — watch whether it stabilises.
W4
Loan growth vs 15-16% guidance: currently ahead at 17% YoY (₹1.04 lakh Cr) — watch for sustainability under the new MD & CEO.
Bank format (in Lakhs, converted to Cr). revenueFromOperations = Interest Earned (matches our 'revenue' series); totalExpenses = total expenditure incl. provisions (₹84.34 Cr std) so totalIncome-totalExpenses=PBT. Exceptional items nil both periods. IFR of ₹119.01 Cr transferred to P&L balance (reserve move, not P&L income). Consolidated adds subsidiary SIB Operations & Services (PAT ₹0.03 Cr) — standalone vs consolidated identical in substance.
Strong delivery masked by QoQ PAT decline; fee weakness unresolved
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Hit NII/NIM guidance, beat loan growth, missed fee recovery, MSME soft. QoQ PAT decline unexplained.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Q1 delivery strong (PAT +17.2% YoY, NIM +28 bps, loan growth 17%) but masked by QoQ PAT decline (−7.3%) and unresolved fee weakness (down 2 qtrs). NIM trajectory positive if rate cycle turns; asset quality excellent (Gross NPA 1.38%). Key risk: MSME growth stalled ('muted'), fee recovery stalling, leadership transition.
₹2627.8 Cr
Revenue · +11.2% YoY₹377.7 Cr
Reported PAT · +17.2% YoYExpanding
Margins · vs guidance: CorroboratedDid the claims hold up?
PAT ₹378 Cr, 17% YoY growth
METDelivered ₹377.7 Cr (17.2% YoY growth)
NII ₹1025 Cr, 23% YoY growth
METHighest ever NII; growth from deposit repricing, CASA growth 15%
Loan growth 17% (18% ex write-off)
METAdvances ₹104,368 Cr; YoY 17% growth vs guidance 15-16%
NIM 3.23%, up 28 bps QoQ, 20 bps YoY
METClawed back deposit repricing impact; rate cycle assumptions hold if cycle turns
MSME loans strong focus with 17% growth
OVERSTATEDGrowth 'muted from expectations'; acknowledged slowdown due to uncertainties
Fee income is one-off; will recover to ₹191 Cr level
OVERSTATEDCore fees ₹179 Cr down from ₹191 Cr (Q4), ₹188 Cr (Q1 last year); weakness consistent 2+ qtrs
Asset quality robust; credit costs at 9 bps describes as 'generous side'
METGross NPA 1.38% (excellent), slippage 12 bps annualizes 48 bps; credit costs likely to normalize upward per guidance
Earnings quality
What changed since the last call
Corporate portfolio 40% vs 30% target
DowngradeAcknowledged deviation from strategy. Rationalized as opportunistic (West Asia, tight liquidity, pricing +40-50 bps). Short-duration; intends to wind down. Deviates from Retail/MSME pivot narrative.
Fee income guidance withdrawn
DowngradePreviously implied recovery; now called 'one-off' with technical fix. Treasury/FX ₹44 Cr (80% below Q1 last year). Core fees ₹179 Cr (down from ₹191 Cr Q4). No recovery timeline given.
MSME growth 'muted' vs prior traction
DowngradeAdmitted growth below expectations due to 'uncertainties' (West Asia). Expecting 'scale mode' to resume Q2. Underlying strategy intact but execution slowed.
NIM guidance upgraded (conditional)
UpgradePrior guidance expected widening; Q1 delivered +28 bps. MD now expects further hardening 'if rate cycle turns' (T+1 sensitivity benefit). Deposit repricing baked in.
Operating leverage target affirmed
NeutralQ1 did NOT achieve it; FY27 target confirmed. OpEx growth 5-6% but revenue growth expected higher (confidence on NII traction, business lines).
The Q&A
Light overall. Analysts pressed on fee weakness (management defensive, claimed technical/one-off), NIM sustainability (hedged on forward rates), MSME slowdown (admitted muted, reassured on recovery). No aggressive challenges. MD's departure reduced willingness to commit on forward guidance.
Deposit repricing, NIM outlook — Akshat Agrawal, Nirmal Bang Institutional Equities
AnsweredHigh-rate deposits rolled off 40-60 bps Jan-Jun. CASA growth 19% helped. Bulk deposits down 50%. Believe substantial repricing baked in. NIM should harden if rate cycle switches to up; currently well positioned but no quantified guidance.
OpEx and branch expansion — Akshat Agrawal, Nirmal Bang Institutional Equities
AnsweredSmall branch rollout restart in key locations (frozen 3 years). Aiming for positive operating leverage (last 2 years achieved; Q1 missed; FY27 target). OpEx 5-6% growth expected. Confidence on NII/business lines expansion to exceed costs.
Fee income weakness — Akshat Agrawal, Nirmal Bang Institutional Equities
PartialOne-off; focused on NIMs. Treasury down 80% (repo environment). FX growing 40-50% YoY; new platform by Sept will boost. Q1 recoveries ₹179 Cr lower than normal (seasonal); expect ₹800-1000 Cr FY27.
Corporate credit overweight — Prashant Kumar, Sunidhi Securities & Finance
AnsweredLong-run aim to bring down. Current environment (West Asia, uncertainties) favors low-risk corporates. Pricing improved dramatically. These are short-duration; will roll off quickly. Onetime adjustment.
Core fee income structural weakness — Suraj Das, Sundaram Mutual Funds
PartialTechnical issue: product renewal process change resulted in lower fees charged (will fix). Treasury/FX muted (separate issue). Overall one-off; will address.
Employee cost actuarial impact — Suraj Das, Sundaram Mutual Funds
AnsweredYes. Q1 actuarial contribution ₹84 Cr back to normal (same as last year Q1). G-SEC movement impact moderated.
Credit cost run rate — Suraj Das, Sundaram Mutual Funds
Answered9 bps 'generous side'; likely to moderate. Slippage ₹500-800 Cr FY27, recoveries ₹800-1000 Cr. SMA-1+2 rise seasonal (Q4 to Q1 normal); reversible.
FCNR deposit growth — Suraj Das, Sundaram Mutual Funds
AnsweredGrowth robust. Offer open until Sept 30. Bulk flows expected Aug-Sep. No credit lines from external entities; no GIFT City presence; leverage not possible. Only unlevered deposits. Landed cost competitive vs domestic liquidity.
SMA-1 and -2 seasonality — Parth Gutka, 360 One Capital
AnsweredSeasonal. Increases Q4 to Q1 every year (prior years confirm). Reviewed constituents; believe reversible; no material risk add.
Gold loan growth slowdown — Parth Gutka, 360 One Capital
AnsweredRBI circular (effective April 1) caused ₹270 Cr runoff in co-lending/portfolio purchases. Branch banking grew nicely. Core growth solid; confident material growth forward.
ECL effective interest rate impact — Jai Mundhra, ICICI Securities
PartialStill working on it. Initial workings show no material change to current NII expected.
DICG insurance repricing — Jai Mundhra, ICICI Securities
AnsweredYes, ₹10 Cr benefit QoQ (~15% full-year reduction).
Corporate yield improvement drivers — Jai Mundhra, ICICI Securities
AnsweredBoth. T-bill movement + market hardening (liquidity tighter). Opportunistic pricing. Retail pricing flat; corporate pricing up considerably.
Capital deployment strategy — Rohit Ahuja, Lotuslion Venture
PartialGrow balance sheet at market + 2%. Shift asset mix (low-risk/low-yield to high-risk/high-yield retail/MSME). ROA migration 100-115 bps today to 120-125 bps over time. Hesitant to bind successor with concrete ROE target.
Leadership continuity — Ravindra, Individual Investor
AnsweredPersonal choice to do other things; age consideration. Cannot speak to prior MD's reasons.
NII sustainability — Ravindra, Individual Investor
AnsweredRepricing advantage may not be same quantum forward. But NII should hold. Rate cycle up (expected) would help via T+1 repo pass-through.
MSME segment growth — Aman, ICICI Securities
PartialGrowth 'muted' from expectation due to uncertainties. Fraternity now operating 'business as usual.' Expecting 'scale mode' return this quarter. Narrative on balance sheet mix change (reduce corporate, increase MSME) intact and on track.
ECLGS scheme utilization — Aman, ICICI Securities
AnsweredLimit ₹400 Cr. Disbursement ₹238 Cr. Utilized ₹50 Cr. Utilization struggle; working to increase contribution progressively.
Guidance
Loan growth 15-16% FY27; Q1 delivered 17%
HighMet and exceeded in Q1; advances ₹104,368 Cr YoY +17%. Retail segments all strong (gold +43%, mortgage +34%, auto +34%). MSME 'muted'; expects recovery. Trend positive.
NIM to widen; Q1 +28 bps QoQ, +20 bps YoY to 3.23%
HighDeposit repricing (40-60 bps) and CASA growth (19%) delivered. 'Substantial repricing baked in'; sharp reduction unlikely forward. Rate-cycle up (expected) would help via T+1 transmission. Reasonably positioned.
Risks the call surfaced
Fee income structural weakness
MediumCore fees ₹179 Cr (Q1) down from ₹191 Cr (Q4), ₹188 Cr (prior year Q1). Treasury/FX 80% below. Management blamed 'technical' product renewal issue, but weakness consistent 2+ quarters. One-off narrative not supported.
Sequential PAT decline
MediumQ1 PAT ₹377.7 Cr is -7.3% QoQ from Q4 FY26 (implied Q4 PAT ~₹408 Cr). Despite NII +23% YoY and cost management, net PAT declined quarter-on-quarter. Unexplained in call; suggests headwinds elsewhere (fee, recoveries, provisions).
MSME growth momentum stalled
MediumBusiness loans (MSME) grew 17% YoY (18% ex-charge-off), but ED Dolphy Jose admitted growth 'muted from expectations' due to 'too many uncertainties' (West Asia). This is core to balance-sheet mix strategy (shift from corporate to MSME). If slowdown persists, strategic pivot at risk.
Corporate portfolio overweight
MediumCorporate now 40% of advances vs 30% strategic target. Growth 17% driven by corporate (short-duration, opportunistic pricing). If West Asia geopolitical stress escalates, corporate defaults could spike. Collateral-light vs gold loans.
Leadership transition
MediumMD P.R. Seshadri announced this is his last earnings call. This is the third MD in 3 years (prior MD also left after 3 years per analyst question). Leadership churn raises questions on strategy continuity, execution pace, and succession quality.
NIM guidance conditional on rate cycle
LowMD said NIM should 'harden' and NII outcomes 'positive' if rate cycle switches to increases. T+1 sensitivity means benefit if repo rises. But if rate cycle stays flat or turns down, NIM tailwind evaporates. No base-case guidance on margins without rate hikes.
Management
Score 7/10. Clear on metrics and drivers. Candid on MSME slowdown, fee weakness, corporate overweight. Evasive on fee recovery timeline (claimed 'one-off' without evidence). Transparent on asset quality and credit guidance (disclosed slippage/recovery ranges). Strong on loan growth (17% vs 15-16% guidance). Delivered NIM +28 bps despite rate cuts (hedged well). Fee recovery missed (₹179 Cr vs historical higher). QoQ PAT -7.3% despite YoY +17.2% suggests uneven execution. MSME 'muted' vs strategic priority.
1 · Aug-Sep 2026
Trade & FX platform launch (end September); expect revenue uplift 40-50% growth trajectory
2 · Q2 FY27
MSME recovery 'back to scale mode' post-uncertainties; guidance to shift mix away from corporate
3 · H2 FY27
Recovery income normalization; guidance ₹800-1000 Cr full-year recoveries (₹179 Cr Q1)
Key risk: MSME growth stalled ('muted'), fee recovery stalling, leadership transition.